“We are delighted to continue backing @CoachHub_IO as it makes huge strides in the US and Asia and builds upon its position as Europe’s leading digital coaching platform.” Investment Director, @MrChrisHornung
Congratulations on the Series B2 raise! 🎉
https://t.co/bu2EOY1Ppz
“It was just a dream job for any composer.” Congratulations are in order for @harryescott as he wins the BAFTA for Original Music on Roadkill! #BAFTATV
Last chance to sign up to join Dr.@ingadeakin for a one-to-one, 20 min virtual session on 19 May.
If you're a founder of a Series A+ #HealthTech seeking funding and support, this is for you.
Sign up here: https://t.co/t57wg0DAZx
Boom! @DraperEsprit leads $20m Series A in @RiverLane_io only a few weeks after following on in $222m Series E in @graphcoreai. That's how you do Deeptech!
Congrats to Steve, Bek and the team at Riverlane. Delighted to work with you in the years to come.
We’re pleased to welcome Dr @ingadeakin as Principal, specialising in Healthtech. With a PhD in Neuroscience and many years of life sciences investing, Inga extends our team's deep knowledge and experience of this vital industry.
🏥💊💉🩸📱🩺⚕️😷
https://t.co/75dDkoe7dx
Our inaugural Global Digital Health Festival kicked off yesterday! Join us as we continue today and talk on Convergence and Collaboration starting at 13:00 CET. Register here to take part until Thursday: https://t.co/7YNygkcNL2
#cmslaw#ai#telemedicine#digitalhealth#HealthTech
How will accessing healthcare change in the future? Join Venture Partner @VishalGulati_ & Principal @ingadeakin tomorrow as they discuss the future of healthcare access with @PushDoctor CEO, Wais Shafta, & Dr. Rozelle Kane, NHS.
Register here; https://t.co/0s9sZNkWhW
Looking forward to #BioBeat20 today #TheCrick "Accelerating data-driven health" feat. Isabel Fox, Heather Roxborough, Pam Garside, Barbara Domayne-Hayman and more...thank you Miranda Weston-Smith #healthtech#digitalhealth https://t.co/EbICrCv6ww
@bobbysoniDK@SatchinPanda Yes! Come on circadian biology, much potential and not as scary for pharma cos as it used to be to have timed treatment regimens if the outcomes are worth it.
Huge thanks to all our new and existing investors who have helped us with our $70 million (€57 Million) fund raising - the largest disclosed #SeriesB financing in the European Biotech sector in 2018! @AnderaPartners#QuanCapital @SofinnovaParis @IPGroupplc@embl & @TakedaPharma
Thoughtful article describing the excellent #digitalhealth company @iesohealth and CEO @DanClarkTx The Doctor Will Text You Now https://t.co/W0xvDMtSCR